A股異動 | 上聲電子跌10% 新能源汽車市場對公司目前的盈利能力影響有限
格隆匯11月25日丨上聲電子跌10.04%,報46.78元,總市值75億元。上聲電子11月24日發佈異動公吿,2021年前三季度,公司供應的產品用在新能源汽車上的銷售額佔公司主營業務收入的比重還不超過20%;功放產品貢獻的收入不足公司主營業務收入的10%;客户特斯拉貢獻的收入不足公司主營業務收入的2%。綜上,新能源汽車市場對公司目前的盈利能力影響有限。若公司汽車電子產品客户拓展不及預期、開發配套放緩、量產進度延遲、客户訂單不及預期,公司經營業績可能承受一定壓力,公司敬請廣大投資者注意投資風險。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.